SEC Form 4 · accession 0001209191-16-092906
CONCERT PHARMACEUTICALS, INC. · CNCE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Robert Silverman
Officer — Senior VP, General Counsel
Period of report
Jan 20, 2016
Accepted (ET)
Jan 21, 2016 · 4:30 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001367920
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 20, 2016 | M | 8,000 | $1.13 | A | 21,415 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $1.13 | Jan 20, 2016 | M | 8,000 | D | — | Jun 4, 2017 | Common Stock | 8,000 | 11,497 | D |
Explanation of responses
- F1This option is fully vested.